Directors Dealing: Proteome Sciences

Proteome Sciences  (LON: Prem)  4.72p  Mkt Cap £14m

The Company has received notification from Richard Dennis, Chief Commercial Officer, that on 12 April and 13 April 2021 he purchased, in aggregate, 625,000 Ordinary Shares in the Company at an average price of 5.22p per share. Richard Dennis now holds 625,000 Ordinary Shares in the Company, which represents approximately 0.21% of the issued share capital of the Company.

Rchard Dennis joined the group in April 2017. He has a commercial background spanning over 30 years in the global life sciences research sector. Throughout his career he has held positions based in both UK and US managing international sales teams. In 1991, he joined Oxford Glycosciences, a VC backed company based in Abingdon UK an...

- Advertisement -

Latest News

More Articles Like This

Tagdiv Cloud library - template content.